Germany Women Health Diagnostics Market Size, Share and Forecast 2019-2025

Germany women health diagnostics market is growing at a CAGR of approximately 9.4% during the forecast period. Germany is expected to grow owing to various factors including government support towards women health. Health insurance is one of the major guidelines enforced by the government of Germany, health insurance is mandatory for all citizens and permanent residents of Germany, which is expected to increase the Germany women health diagnostic during the forecast period. It is provided by two systems, that is competing, not-for-profit, nongovernmental health insurance funds in the statutory health insurance (SHI) system and substitutive private health insurance (PHI).

Request a Free Sample of our Report on Germany Women Health Diagnostics Market: https://www.omrglobal.com/request-sample/germany-women-health-diagnostics-market

States own most university hospitals, while municipalities play a role in public health activities and own about half of all hospital beds. Though, the various levels of government have virtually no role in the direct financing or delivery of health care. This health insurance insures the women in any critical illness such as cancer, STDs and many others. Thus, such initiatives and programs by the government are projected to propel the growth of the Germany women health diagnostic market.
Further, for various screening and tests including cancer and contraception, the government provides various facilities for women in the region.

For instance, for cancer screening, every woman over the age of 20, both state-funded and private health insurance in Germany covers an annual exam at the gynecologist for the checkup for early symptoms of cervical cancer, ovary cancer, breast cancer, and any other reproductive related cancer. Whereas, for contraception, all usual methods of contraception are given, though, hormonal contraceptives (the birth control pill, implants, injections), IUDs (intra-uterine devices such as the spiral) are prescribed by a gynecologist. Hence, the availability of such options contributes to enhancing women health and in turn aids in the growth of the German women's health diagnostic market.

A Full Report of Germany Women Health Diagnostics Market is Available at https://www.omrglobal.com/industry-reports/germany-women-health-diagnostics-market

Germany Women Health Diagnostics Market Segmentation

By Applications
o Breast Cancer Testing
o Cervical Cancer Testing
o Pregnancy & Fertility Testing
o Ovarian Cancer Testing
o Infectious Disease Testing
o Ultrasound Tests
o Sexually Transmitted Disease Testing
o Others (Osteoporosis Testing and Prenatal Genetic Testing)

By End-User
o Diagnostic and Imaging Centers
o Hospitals and Clinics
o Home Care

Company Profiles
o Abbott Laboratories, Inc.
o Becton, Dickson and Co.
o Biomerieux SA
o EKF Diagnostics Holdings PLC
o F. Hoffmann-La Roche Ltd.
o GenMark Diagnostics, Inc.
o Hologic Inc.
o Koninklijke Philips N.V.
o Nova Biomedical Pte. Ltd.
o PerkinElmer Inc.
o QIAGEN N.V.
o Siemens AG
o Thermo Fisher Scientific Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/germany-women-health-diagnostics-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.